Home

Sarcopenia diagnosis and treatment

Sarcopenia from mechanism to diagnosis and treatment in

Radiological image analysis is currently utilized to diagnose sarcopenia in cirrhosis. Nutrient supplementation and physical activity are used to counter sarcopenia but have not been consistently effective because the underlying molecular and metabolic abnormalities persist or are not influenced by these treatments Sarcopenia: Diagnosis and treatment J. E. Morley 1 , 2 The Journal of Nutrition Health and Aging volume 12 , Article number: 452 ( 2008 ) Cite this articl Sarcopenia is now formally recognised as a muscle disease with an ICD-10-MC Diagnosis Code that can be used to bill for care in some countries [7, 8]. Even though healthcare professionals today are better at recognising sarcopenia, many research findings have not yet been translated into clinical practice The main treatment path for sarcopenia is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to people with sarcopenia. This training..

Lifestyle interventions, especially exercise and nutritional supplementation, prevail as mainstays of treatment. Further research is needed to investigate potential long-term benefits of lifestyle interventions, nutritional supplements, or pharmacotherapy for sarcopenia in Asians The essential supplement you need for treating sarcopenia is protein. It is essential for gaining and maintaining strength and improving mobility. The Mayo Clinic recommends people with, or at risk for sarcopenia should eat 1.2 to 1.5 grams of protein per kilogram of weight, or about 3.5-4.3 ounces for an adult who weighs 180 pounds Diagnosis of sarcopenia in cirrhosis. and recent studies have reported that sarcopenia is an independent prognostic factor decreasing survival and increasing treatment related mortality in patients with HCC ,

Sarcopenia: Diagnosis and treatment SpringerLin

robust evidence to assess the strength of other treatment options. Key words: Sarcopenia/diagnosis, sarcopenia/therapy, muscle strength, aged, 80 and over, practice guideline. Serdi and Springer-Verlag International SAS, part of Springer Nature J Nutr Health Aging. 2018;22(10):1148-116 Treatment Currently, there are no medications approved by the U.S. Food and Drug Administration (FDA) to treat sarcopenia. Some research is investigating the use of hormone therapy to increase lean.. Sarcopenia Treatment While everyone loses some muscle mass with age, natural sarcopenia treatment can slow or even reverse that loss. For the elderly, maintaining muscle mass and function is vital to having functional independence. Muscle deterioration can be prevented, decreased and reversed with the following sarcopenia treatment methods We define sarcopenic respiratory disability as a disability with deteriorated respiratory function due to respiratory sarcopenia. This article describes age-related respiratory decline, the diagnostic criteria for respiratory sarcopenia and sarcopenic respiratory disability, and rehabilitation nutrition management as a treatment The Japanese Working Group of Respiratory Sarcopenia of the Japanese Association of Rehabilitation Nutrition narratively reviews thes Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment J Nutr Health Aging. 2021;25(4):507-515. doi: 10.1007/s12603-021-1587-5..

Treatment of this syndrome should include osteoporotic drugs [bone anabolics/antiresorptives (i.e. teriparatide, denosumab, bisphosphates)] where indicated, and progressive resistance and balance exercises (at least 2-3 times/week) Drug treatment Pharmacological treatment of sarcopenia is a major area for research. Many drugs are being tested for their effects on muscle mass and strength, such as Ghrelin, GH secretagogue and myostatin inhibitor, but at present few results have been achieved, some of which are controversial The primary treatment for sarcopenia is exercise, specifically resistance training or strength training. These activities increase muscle strength and endurance using weights or resistance bands...

Diagnosis, treatment, and prevention of sarcopenia is likely to become part of routine clinical practice. Introduction Sarcopenia is a term derived from the Greek phrase poverty of flesh. It was first described in the 1980s as an age-related decline in lean body mass affecting mobility, nutritional status, and independence.1 The definition has. Below is a list of common natural remedies used to treat or reduce the symptoms of Sarcopenia. Follow the links to read common uses, side effects, dosage details and read user reviews for the. Definition. The interest about sarcopenia, the age-related loss of skeletal muscle mass and function, is growing considerably. In 1989, Rosenberg proposed the term 'sarcopenia' (Greek 'sarx' or flesh + 'penia' or loss) to describe this age-related decrease of muscle mass (1, 2).Although sarcopenia is primarily a disease of the elderly, its development may be associated with.

Sarcopenia: revised European consensus on definition and

  1. Title:Sarcopenia: An Overview on Current Definitions, Diagnosis and Treatment VOLUME: 19 ISSUE: 7 Author(s):Francesco Landi*, Riccardo Calvani, Matteo Cesari, Matteo Tosato, Anna Maria Martone, Elena Ortolani, Giulia Savera, Sara Salini, Alex Sisto, Anna Picca and Emanuele Marzetti Affiliation:Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart.
  2. Sarcopenia is also more common in a number of other health conditions that increase stress on the body. For example, people with chronic liver disease, and up to 20% of people with chronic heart.
  3. symptoms were worsening as a result of sarcopenia or as a natural result of aging. Participants provided rich detail and insight into the toll that sarcopenia takes on their lives. I
  4. Although skeletal muscle strength and mass are both still considered fundamental to a definitive clinical diagnosis, AWGS 2019 also introduces possible sarcopenia, defined by either low muscle strength or low physical performance only, specifically for use in primary health care or community-based health promotion, to enable earlier lifestyle interventions
  5. Sarcopenic dysphagia is a swallowing disorder due to sarcopenia involving the whole-body skeletal muscles and swallowing muscles. This scoping review aimed to explore the currently known information on the diagnosis and treatment of sarcopenic dysphagia and to clarify the types of research required to develop the field. We searched the PubMed, MEDLINE, CINAHL, and Cochrane databases from their.

Diagnosis of sarcopenia in cirrhosis. and recent studies have reported that sarcopenia is an independent prognostic factor decreasing survival and increasing treatment related mortality in patients with HCC , Sarcopenia, defined as the loss of muscle strength, is considered one of the leading causes of disability in older people and its prevalence increases with age. Those who suffer Sarcopenia have higher rates of disability and dependence. Despite numerous investigations, there are no standardized diagnostic criteria for Sarcopenia

Sarcopenia: Symptoms, Causes, Treatment, and Preventio

A true diagnosis of sarcopenia is confirmed with low muscle quantity or quality. 4 And sarcopenia is considered severe when low physical performance is also noted. It is estimated that up to 29% of community-dwelling adults over 65 years of age and 14-33% of older adults living in care facilities meet the definition for sarcopenia. Sarcopenia has become the focus of intense research aiming to translate current knowledge about its pathophysiology into improved diagnosis and treatment, with particular interest in the development of biomarkers, nutritional interventions, and drugs to augment the beneficial effects of resistance exercise Sarcopenia treatment. For the management of sarcopenia, there is a strong recommendation that individuals with sarcopenia should be enrolled in a resistance exercise programme 85). There is a reasonable amount of evidence that resistance exercise will increase both muscle mass and strength 86) sarcopenia.13 With the new ICD-10 code, greater advancements in the prevention, diagnosis, and treatment of sarcopenia in older adults are in progress. This is an important step to ensure patients can receive the proper clinical care Slowing or reversing muscle loss — Researcher Nathan K. LeBrasseur, Ph.D., discusses the discovery that the growth and differentiation factor-8 functions as a potent negative regulator of muscle growth, and whether it can serve as a mediator of sarcopenia or cachexia and as a therapeutic target

criteria: Sarcopenia, hip fractures, diagnosis, treatment, and prevention with a minimum average of 6-months follow-up. Any evidence-level studies reporting clinical data and dealing with sarcopenia diagnosis, or the treatment and prevention in hip fracture-a ected patients, were considered. Results: A total of 32 articles were found The diagnosis and treatment of sarcopenia in older adults should be holistic and take chronic condition management into consideration. To promote early intervention in seniors at risk of or with sarcopenia, AWGS 2019 included the definition of possibl In cases where sarcopenia progresses, is not diagnosed and treated early, the disease can have fatal consequences. When the diagnosis and treatment of the disease is delayed, it is only possible to extend the life span of the patients at least a few years by treatment methods such as physical therapy, exercise and proper nutrition In this review, we will discuss the muscle and bone mass loss in the elderly population and advances in diagnosis and treatment. Keywords: Sarcopenia, Osteopenia, Osteoporosis Human aging is an irreversible and inexorable process characterized by morphological, functional and biochemical changes in the human body, including the musculoskeletal. A co-diagnosis of sarcopenia with cancer is associated with poorer tolerance of treatment, poorer response to treatment, and negative outcomes as a whole. This session will present the science regarding the development of sarcopenia in the cancer patient, as well as strategies for RDNs to identify sarcopenia in oncology patients

Background: Sarcopenia is defined as a progressive loss of muscle mass and muscle strength associated to increased adverse events, such as falls and hip fractures. The aim of this systematic review is to analyse diagnosis methods of sarcopenia in patients with hip fracture and evaluate prevention and treatment strategies described in literature The use of l-leucine supplementation can have some beneficial effects on sarcopenia and could be considered for the treatment of sarcopenia in older individuals. Full article (This article belongs to the Special Issue Sarcopenia: From Diagnosis to Health Consequences and Nutritional Treatment sarcopenia as whole-body sarcopenia and low respiratory muscle mass followed by low respiratory muscle strength and/ or deteriorated respiratory function. Moreover, we propose an algorithm for the diagnosis of respiratory sarcopenia. RESPIRATORY SARCOPENIA AND SARCOPENIC RESPIRATORY DISABILITY: CONCEPTS, DIAGNOSIS, AND TREATMENT

Asian Working Group for Sarcopenia: 2019 Consensus Update

Fourth, sarcopenia has been overlooked and undertreated in mainstream practice , apparently due to the complexity of determining what variables to measure, how to measure them, what cut-off points best guide diagnosis and treatment, and how to best evaluate effects of therapeutic interventions . To this end, EWGSOP2 aims to provide clear. Clinical and research interest in sarcopenia has burgeoned internationally, Asia included. The Asian Working Group for Sarcopenia (AWGS) 2014 consensus defined sarcopenia as age-related loss of muscle mass, plus low muscle strength, and/or low physical performance and specified cutoffs for each diagnostic component; research in Asia consequently flourished, prompting this update Sarcopenia Treatment. Sarcopenia is often coupled with other diseases related to aging, making its effects even more problematic and increasing your risk factors for age-related disability. For instance, the risk of falls and bone injury is greater if you suffer from both osteoporosis and sarcopenia. Preventing or treating sarcopenia reduces. Sarcopenia is a progressive disease that mainly affects individuals over the age of 50 - affecting balance, strength and the overall ability to complete everyday activities. While Sarcopenia can decrease life expectancy, it primarily affects a person's overall quality of life, leading to: Falls and fractures. Weight loss and/or malnutrition Sarcopenia, defined as a syndrome rather than as a pathology, is the loss of muscle mass and function associated with age. Sarcopenia is an enigma for medicine, and despite the numerous publications available in the literature and the number of papers currently being published, there is no agreement about its definition, and even less about its root causes

Sarcopenia is the loss of skeletal muscle mass, strength and function associated with the aging process. Sarcopenia is an important clinical problem that impacts millions of older adults Unlike diagnosis based on DEXA alone, the diagnosis of sarcopenia based on grip strength is associated with mortality, hip fracture, falls, mobility disability and IADL disability. Cut-off points in grip strength or grip strength/BMI are the best tools to identify women (and men) at risk for mobility disability

Sarcopenia is very common, with a prevalence of ∼5% in persons aged 65 years and as high as 1 in two persons over the age of 80 years. Sarcopenia is commonly associated with disability and has been estimated to cost the US health system ∼$18.4 billion a year. 2. Sarcopenia leads to a decline in muscle strength and power A workable diagnosis criterion for sarcopenia is the combination of low muscle mass and low muscle strength or low physical performance . Whilst specific diagnostic criteria for sarcopenia have been published there is still no commonly used, cheap, easy-to-administer diagnostic test to identify patients with sarcopenia The European Working Group on Sarcopenia in Older People (EWGSOP) recently published consensus guidelines on the definition and diagnosis of sarcopenia. This definition was an important development in sarcopenia research and has provided a systematic approach not only in case finding but also in understanding aetiology and developing treatments Newcastle University experts are chairing a national session on new guidelines for the early detection and treatment of sarcopenia -- a loss of muscle strength that affects many older people in.

manpower required for sarcopenia diagnosis and treatment. 4.5 | Strengths and limitations This is the first study assessing the knowledge and practice of sarcopenia among health‐care professionals after sarcope nia was recognised as a disease in October 2016. In addition Phase 2 trial (ONO-7643-04) for the treatment of patients with non-small cell lung cancer and cachexia resulted in 1.56 kg lean body mass increase assessed by dual-energy X-ray absorptiometry (DXA). 5 Changes in lean body mass, body weight, and anorexia symptoms showed significant differences in the treatment arm compared with the placebo arm. The prevalence of sarcopenia in men 60 years and older is 11.6% and 38.6% in the 80s, which indicates that a high proportion of the people suffer from sarcopenia. Symptoms of Sarcopenia. If the loss of muscles worsens because of sarcopenia, the speed in overall body malfunction is dramatically increased 3.4 Sarcopenia treatment in clinical practice. Table 3 shows the sarcopenia treatment in clinical practice before and 6 months after attendance. For those who were responsible to provide sarcopenia treatment, there was an increase in providing resistance exercise from 12.4% before attendance to 28.6% at 6 months of follow-up, while adequate. The diagnosis of sarcopenia has no uniform standard due to the influence of race, age, and gender. Currently, there is no particularly effective treatment strategy for this disease. CHF is a complex clinical syndrome with hundreds of years of history

Sarcopenia Treatment: How to Manage the Symptoms - StrongPat

Sarcopenia directly translates to loss of flesh. He is a proponent of patient education as a tool in the diagnosis and treatment of acute and chronic medical conditions. New Year New You: Health Tips All Seniors Should Know. Common Causes of Falls in Seniors. Ways to Improve Body Awareness and Prevent Falls Sarcopenia is characterized by: 1. A muscle atrophy (a decrease in the size of the muscle), 2. A reduction in muscle tissue quality Symptoms of muscle loss are: 1. Musculoskeletal weakness 2. Loss of stamina, 3. Reduced physical activity The primary treatment for sarcopenia is exercise Sarcopenia: 2020. Over the last 20 years sarcopenia has been recognized as a major geriatric syndrome with its own ICD-10-CM billable code (M62:84) ( 1) Numerous societies have recognized it should be diagnosed by having a low measurement of muscle strength, e.g., grip strength, as well as a low fat free mass ( 2 - 5 )

Newcastle University experts are chairing a national session on new guidelines for the early detection and treatment of sarcopenia—a loss of muscle strength that affects many older people in the UK In this article, we review the pathophysiology, diagnosis and treatment of two such comorbidities, osteoporosis and sarcopenia, as they relate to patients with COPD. Introduction Chronic obstructive pulmonary disease (COPD) is a multisystem disorder, characterized by involvement of multiple organs in addition to the lungs [ 1 ] Scope of Sarcopenia Treatment Market: Sarcopenia is a type of muscle loss (muscle atrophy) that occurs with aging and/or immobility. It is characterized by the degenerative loss of skeletal muscle. Diagnosis of Sarcopenia in cirrhosis. Most studies to date have used the term malnutrition to identify primarily skeletal muscle loss determined by one or more criteria that are not always uniform or precise and an alteration in energy metabolism and potentially fat mass depletion Morley, J.E. (2008) Sarcopenia Diagnosis and Treatment. The Journal of Nutrition Health and Aging, 12, 452-456

The main symptoms of sarcopenia are decreased muscle mass and strength. As a result, other symptoms and effects of sarcopenia include frailty, problems with mobility, falls and fractures, decreased activity levels (which only makes sarcopenia worse), loss of independence, weak bones, and weight gain from lack of activity eter of the diagnosis, the best measure of muscle function. The loss of skeletal muscle mass assessed by dual-energy X-ray absorptiometry, bioelectric impedance analysis, computer tomography, or magnetic resonance imaging con-firms diagnosis, while the decrease in physical performance reflects severe sarcopenia. For the treatment and preven

Sarcopenia: Causes, symptoms, and managemen

  1. sarcopenia a growing global public health concern that requires proven, accessible, cost effective and sustainable approaches to its prevention, delay, treatment and reversal (6-9). Treatments for sarcopenia have focused mostly on extrinsic approaches such as exercise and diet, but recent scientifi
  2. Update on Sarcopenia Diagnosis and Treatment in Asia: What's Different? *Liang-Kung Chen 1,2. 1 Aging and Health Research Center, National Yang Ming University, Taipei, Taiwan. 2 Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan
  3. A diagnosis of sarcopenia means an increased risk for falls and hip fracture, and a shortened lifespan. More Information on Dr. Williams: For current patients, order pharmaceutic grade supplements from Dr. Williams' protocols on Wellevate or Fullscript
  4. e whether Australian.
  5. The National Institute on Aging, using research on the disease, recently recommended criteria for standardizing the diagnosis of severe sarcopenia, which includes walking less than 31.5 inches per.
  6. Keywords: Sarcopenia, skeletal muscle strength and mass, physical performance, diagnosis, treatment, Asia SFP2021; 47(6) : 5-12 INTRODUCTION Sarcopenia is a term derived from Greek meaning 'poverty of flesh' and was first proposed by Irwin Rosenberg in 1989 to describe the age-associated loss of muscle mass. In th
  7. Sarcopenia or loss of skeletal muscle mass is the major component of malnutrition and is a frequent complication in cirrhosis that adversely affects clinical outcomes. These include survival, quality of life, development of other complications and post liver transplantation survival. Radiological image analysis is currently utilized to diagnose sarcopenia in cirrhosis

Sarcopenia: Symptoms, Causes & 10 Natural Treatments

Respiratory Sarcopenia and Sarcopenic Respiratory

Age-related loss of the skeletal muscle and its function is known as sarcopenia. Definition and diagnostic criteria for sarcopenia have been outlined as consensus statements from several study groups, including usual gait speed, grip strength, and skeletal muscle mass. Whereas underlying mechanisms and pathophysiology of sarcopenia remains to be clarified, recent studies have suggested that. In a new study, researchers compared the risk of death for women with breast cancer who had low skeletal muscle mass, or sarcopenia, at diagnosis and women who had adequate muscle mass. Learn what they found and what it might mean for patients in this Cancer Currents blog post

Sarcopenia

Osteosarcopenia: epidemiology, diagnosis, and treatment

Sarcopenia in the elderly: Diagnosis, physiopathology and

  1. The diagnosis of sarcopenia was conducted according to the criteria of the Foundation for National Institute of Health. The final sample consisted of 83 patients in the DG and 83 in the CG. The DG had higher BMI, WC, past history of fractures and lower calcium and healthy diet intake (p < 0.005), compared to the CG
  2. Prevention and Treatment. Any Sarcopenia prevention or treatment program needs firstly to avoid the loss of muscle by atrophy and secondly to avoid the accumulation of fat. It should also aim to recuperate lost muscle mass if at all possible. This can be done through exercise, nutrition and carefully controlled supplementation
  3. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Liang Kung Chen, Jean Woo, Prasert Assantachai, Tung Wai Auyeung, Ming Yueh Chou, Katsuya Iijima, Hak Chul Jang, Lin Kang,.
  4. Increased the diagnosis and treatment of sarcopenia by allowing medical professionals to get reimbursed for their screening time Provided a way to collect data on sarcopenia Though research points to the need for medications and other prescribed treatments, little can be done until policymakers and the medical community overcome significant.

Sarcopenia (Muscle Loss With Aging): Symptoms, Causes, and

New guidelines for early detection and treatment of sarcopenia. Published on: 16 November 2018. Newcastle University experts have chaired a national session on new guidelines for the early detection and treatment of sarcopenia - a loss of muscle strength that affects many older people in the UK Sarcopenia Treatment There is no approved drug for sarcopenia but some health care professionals recommend the use of hormone therapy to improve the patient's muscle mass. Although, there is no exact cure for sarcopenia and the use of hormone therapy is yet to study, there are ways to prevent its onset Professors Sayer and Witham's work at Newcastle University and the NIHR Newcastle Biomedical Research Centre harnesses scientific expertise, input from patients, the public and industry, in order to improve the diagnosis, treatment and prevention of ageing syndromes, including sarcopenia Sarcopenia symptoms manifest gradually over a period of years, so the disease is not typically noticed until after the disease process is well under way and significant muscle mass has been lost. Muscle mass peaks in your 20s and 30s, but the process of sarcopenia can start in your 40s and will usually accelerate tremendously in your 70s The present review is limited by heterogeneity in the definition of sarcopenia and in the methodological approaches in assessing sarcopenia. Future studies are needed to standardize the sarcopenia diagnosis and muscle function assessment, particularly in the pediatric population, to enable early identification and treatment of sarcopenia in.

In this perspective, this study proposes the development of a tool for the diagnosis of having sarcopenia with good specificity and good sensitivity and of low cost and useful. Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307. 3. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population. Introduction. Sarcopenia, the age-related loss of skeletal muscle mass and function, is coming of age. It is now recognised as a major clinical problem for older people and research in the area is expanding exponentially [].This interest stems from the fact that sarcopenia is both common and associated with serious health consequences in terms of frailty, disability, morbidity and mortality New guidelines for the early detection and treatment of sarcopenia were established by the experts of Newcastle University. Sarcopenia is a significant loss of muscle strength that affects. In this review, we will discuss the muscle and bone mass loss in the elderly population and advances in diagnosis and treatment. Keywords: Sarcopenia, Osteopenia, Osteoporosis . Muscle and Bone Mass Loss Measured by Dual X-ray absorptiometry (DXA) in the Elderly Populatio

Therefore, management of sarcopenia should be conducted together in parallel with ovarian cancer treatment and surveillance. Thus, in this article, we will review the clinical importance of sarcopenia in the aspect of ovarian cancer. Definition of sarcopenia, diagnosis, etiology, and intervention will be also introduced. Keyword Sarcopenia Pipeline Insight. DelveInsight's, Sarcopenia - Pipeline Insight, 2021, report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Sarcopenia pipeline landscape.It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and. Sarcopenia is a loss of both coordination and muscle mass, which can result in poor balance, difficulty walking, and finding daily activities become more difficult to perform. Sarcopenia can lead to disability and lack of independence, as well as increasing the risk of falls, fractures or injuries. In addition to a loss of muscle mass, there is. Diagnosing sarcopenia will have to lead to treatment strategies that would otherwise not be triggered as part of current care. The treatments proven to work so far - resistance training and nutrition intervention - are not unique to sarcopenia and are already indicated for the related syndrome of frailty

Common Vitamins and Supplements to Treat sarcopeni

Symptoms of Sarcopenia include decrease in muscle size, weakness, loss of endurance, trouble in climbing stairs and poor balance. As such there is no approved treatment available for sarcopenia, however nutrition and dietary supplements can play an important role in its treatment. Nutrition prevents accelerated muscle loss during the period of. Sarcopenia causes dysphagia and respiratory dysfunction, which prolongs the disease treatment period [5, 6, 7]. Sarcopenia is also one of the factors related to the severity of cardiovascular disease and cancer, and sarcopenia affects survival rates for patients . Therefore, sarcopenia is an important topic in men's health and aging DelveInsight's Sarcopenia market report gives a thorough understanding of the disease by including details such as disease definition, symptoms, types, grading, pathophysiology, and diagnosis. It also provides sarcopenia treatment algorithms and treatment guidelines in the US, Europe, and Japan Muscle atrophy is the loss of skeletal muscle mass. It can be caused by immobility, aging, malnutrition, medications, or a wide range of injuries or diseases that impact the musculoskeletal or nervous system.Muscle atrophy leads to muscle weakness and causes disability

Sarcopenia: an emerging geriatric giant | GMPulmonary Edema - Pictures, Symptoms, Treatment, CausesEpiscleritis - Pictures, Symptoms, Treatment, CausesLeishmaniasis - Pictures, Symptoms, Treatment, Life CycleSpider Angioma - Symptoms, Causes, Pictures, Treatment